From COVID Vaccines to HIV Prevention: Pharmaceutical Financing and Distribution for the Public's Health.
J Law Med Ethics
; 50(S1): 29-31, 2022.
Article
in English
| MEDLINE | ID: covidwho-1960155
ABSTRACT
The complexity and inefficiency of the U.S. health care system complicates the distribution of life-saving medical technologies. When the public health is at stake, however, there are alternatives. The proposal for a national PrEP program published in this issue of the Journal applies some of the lessons of the national COVID vaccine campaign to HIV prevention. In doing so, it draws on other examples of public health approaches to the financing of medical technology, from vaccines for children to hepatitis C treatment.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vaccines
/
HIV Infections
/
COVID-19
Topics:
Vaccines
Limits:
Child
/
Humans
Language:
English
Journal:
J Law Med Ethics
Journal subject:
Nursing
/
Ethics
/
Jurisprudence
/
Medicine
/
Health Services Research
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS